Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569683384> ?p ?o ?g. }
- W1569683384 abstract "Chronic antipsychotic drug treatment may cause tardive dyskinesia (TD), a long-term movement disorder. Gamma-aminobutyric acid (GABA) agonist drugs, which have intense sedative properties and may exacerbate psychotic symptoms, have been used to treat TD.To determine the clinical effects of GABA agonist drugs (baclofen, gamma-vinyl-GABA, gamma-acetylenic-GABA, progabide, muscimol, sodium valproate and tetrahydroisoxazolopyridine (THIP) for people with schizophrenia or other chronic mental illnesses who also developed neuroleptic-induced tardive dyskinesia.We updated the previous Cochrane review by searching the Cochrane Schizophrenia Group Register (June 2010).We included reports if they were controlled trials dealing with people with neuroleptic-induced TD and schizophrenia or other chronic mental illness who had been randomly allocated to either non-benzodiazepine GABA agonist drugs with placebo or no intervention.Working independently, we selected and critically appraised studies, extracted data and analysed on an intention-to-treat basis. Where possible and appropriate we calculated risk ratios (RR) and their 95% confidence intervals (CI) with the number needed to treat (NNT). For continuous data we calculated mean differences (MD).We identified eight small poorly reported studies for inclusion. For the outcome of 'no clinically important improvement in tardive dyskinesia' GABA agonist drugs were not clearly better than placebo (n = 108, 3 RCTs, RR 0.83 CI 0.6 to 1.1). Deterioration in mental state was more likely to occur in people receiving GABA medication (n = 95, 4 RCTs, RR 2.47 CI 1.1 to 5.4), but this effect was influenced by the decision to assign a negative outcome to those who left early before the end of the study. A greater proportion of people allocated GABA medication may fail to complete the trial compared with those allocated placebo (20% versus 9%), but this difference was not statistically significant (n = 136, 5 RCTs, RR 1.99 CI 0.8 to 4.7). There is a suggestion of an increase in ataxia (loss of power of muscular coordination) for both baclofen and sodium valproate (n = 95, 2 RCTs, RR 3.26 CI 0.4 to 30.2), and in sedation (n = 113, 3 RCTs, RR 2.12 CI 0.8 to 5.4) compared with placebo, but this was not significant. Withdrawal of tetrahydroisoxazolopyridine (THIP) may cause seizures.Evidence of the effects of baclofen, progabide, sodium valproate, or THIP for people with antipsychotic-induced TD is inconclusive and unconvincing. Any possible benefits are likely to be outweighed by the adverse effects associated with their use." @default.
- W1569683384 created "2016-06-24" @default.
- W1569683384 creator A5002398914 @default.
- W1569683384 creator A5033299586 @default.
- W1569683384 creator A5034841196 @default.
- W1569683384 creator A5083160550 @default.
- W1569683384 date "2011-04-13" @default.
- W1569683384 modified "2023-10-17" @default.
- W1569683384 title "Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia" @default.
- W1569683384 cites W100452663 @default.
- W1569683384 cites W1482734129 @default.
- W1569683384 cites W1591259115 @default.
- W1569683384 cites W1598602811 @default.
- W1569683384 cites W1850357518 @default.
- W1569683384 cites W1902532212 @default.
- W1569683384 cites W1963846290 @default.
- W1569683384 cites W1964162160 @default.
- W1569683384 cites W1974170301 @default.
- W1569683384 cites W1977185679 @default.
- W1569683384 cites W1978040764 @default.
- W1569683384 cites W1980077014 @default.
- W1569683384 cites W1982577374 @default.
- W1569683384 cites W1984419447 @default.
- W1569683384 cites W1987468576 @default.
- W1569683384 cites W1992857340 @default.
- W1569683384 cites W1993810025 @default.
- W1569683384 cites W1993943040 @default.
- W1569683384 cites W1995762908 @default.
- W1569683384 cites W1998381822 @default.
- W1569683384 cites W2002392244 @default.
- W1569683384 cites W2003885112 @default.
- W1569683384 cites W2008061513 @default.
- W1569683384 cites W2019523598 @default.
- W1569683384 cites W2020844317 @default.
- W1569683384 cites W2021701993 @default.
- W1569683384 cites W2023839473 @default.
- W1569683384 cites W2024696043 @default.
- W1569683384 cites W2025868325 @default.
- W1569683384 cites W2028752506 @default.
- W1569683384 cites W2032248619 @default.
- W1569683384 cites W2032712358 @default.
- W1569683384 cites W2043964673 @default.
- W1569683384 cites W2048081131 @default.
- W1569683384 cites W2053177239 @default.
- W1569683384 cites W2053494142 @default.
- W1569683384 cites W2058874144 @default.
- W1569683384 cites W2059502657 @default.
- W1569683384 cites W2064640550 @default.
- W1569683384 cites W2080254657 @default.
- W1569683384 cites W2106040150 @default.
- W1569683384 cites W2107448795 @default.
- W1569683384 cites W2122537086 @default.
- W1569683384 cites W2125435699 @default.
- W1569683384 cites W2130235475 @default.
- W1569683384 cites W2135029321 @default.
- W1569683384 cites W2136545364 @default.
- W1569683384 cites W2157823046 @default.
- W1569683384 cites W2237507496 @default.
- W1569683384 cites W2331242089 @default.
- W1569683384 cites W2341042406 @default.
- W1569683384 cites W2400402487 @default.
- W1569683384 cites W2400976164 @default.
- W1569683384 cites W2465896322 @default.
- W1569683384 cites W27393489 @default.
- W1569683384 cites W4205107596 @default.
- W1569683384 cites W4214559180 @default.
- W1569683384 cites W4247528944 @default.
- W1569683384 cites W4250504183 @default.
- W1569683384 cites W4252732906 @default.
- W1569683384 cites W4253855482 @default.
- W1569683384 cites W4320288061 @default.
- W1569683384 cites W2057134027 @default.
- W1569683384 doi "https://doi.org/10.1002/14651858.cd000203.pub3" @default.
- W1569683384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21491376" @default.
- W1569683384 hasPublicationYear "2011" @default.
- W1569683384 type Work @default.
- W1569683384 sameAs 1569683384 @default.
- W1569683384 citedByCount "29" @default.
- W1569683384 countsByYear W15696833842012 @default.
- W1569683384 countsByYear W15696833842013 @default.
- W1569683384 countsByYear W15696833842015 @default.
- W1569683384 countsByYear W15696833842016 @default.
- W1569683384 countsByYear W15696833842017 @default.
- W1569683384 countsByYear W15696833842018 @default.
- W1569683384 countsByYear W15696833842022 @default.
- W1569683384 crossrefType "journal-article" @default.
- W1569683384 hasAuthorship W1569683384A5002398914 @default.
- W1569683384 hasAuthorship W1569683384A5033299586 @default.
- W1569683384 hasAuthorship W1569683384A5034841196 @default.
- W1569683384 hasAuthorship W1569683384A5083160550 @default.
- W1569683384 hasConcept C118552586 @default.
- W1569683384 hasConcept C126322002 @default.
- W1569683384 hasConcept C142724271 @default.
- W1569683384 hasConcept C15744967 @default.
- W1569683384 hasConcept C170493617 @default.
- W1569683384 hasConcept C204787440 @default.
- W1569683384 hasConcept C27081682 @default.
- W1569683384 hasConcept C2776412080 @default.
- W1569683384 hasConcept C2777123777 @default.
- W1569683384 hasConcept C2778173252 @default.